HEADER TRANSFERASE/INHIBITOR 29-NOV-18 6IUP TITLE CRYSTAL STRUCTURE OF FGFR4 KINASE DOMAIN IN COMPLEX WITH COMPOUND 5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 445-753; COMPND 5 SYNONYM: FGFR-4; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.XU,Q.LIU REVDAT 2 22-NOV-23 6IUP 1 REMARK REVDAT 1 06-NOV-19 6IUP 0 JRNL AUTH Y.WANG,Y.DAI,X.WU,F.LI,B.LIU,C.LI,Q.LIU,Y.ZHOU,B.WANG,M.ZHU, JRNL AUTH 2 R.CUI,X.TAN,Z.XIONG,J.LIU,M.TAN,Y.XU,M.GENG,H.JIANG,H.LIU, JRNL AUTH 3 J.AI,M.ZHENG JRNL TITL DISCOVERY AND DEVELOPMENT OF A SERIES OF JRNL TITL 2 PYRAZOLO[3,4-D]PYRIDAZINONE COMPOUNDS AS THE NOVEL COVALENT JRNL TITL 3 FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS BY THE RATIONAL JRNL TITL 4 DRUG DESIGN. JRNL REF J.MED.CHEM. V. 62 7473 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31335138 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00510 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX V1.0 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.12 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 40618 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 2025 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 10.0000 - 4.8150 0.97 2720 139 0.1726 0.2404 REMARK 3 2 4.8150 - 3.8238 0.99 2730 146 0.1410 0.1973 REMARK 3 3 3.8238 - 3.3410 0.98 2749 146 0.1514 0.1904 REMARK 3 4 3.3410 - 3.0358 0.98 2749 144 0.1680 0.2218 REMARK 3 5 3.0358 - 2.8184 0.99 2759 142 0.1789 0.2281 REMARK 3 6 2.8184 - 2.6523 0.99 2708 144 0.1799 0.2464 REMARK 3 7 2.6523 - 2.5195 0.99 2815 149 0.1778 0.2152 REMARK 3 8 2.5195 - 2.4099 0.99 2747 144 0.1679 0.2405 REMARK 3 9 2.4099 - 2.3171 0.99 2796 147 0.1700 0.2317 REMARK 3 10 2.3171 - 2.2372 0.99 2735 142 0.1774 0.2349 REMARK 3 11 2.2372 - 2.1672 0.99 2791 150 0.1921 0.2849 REMARK 3 12 2.1672 - 2.1053 0.99 2736 140 0.1909 0.2559 REMARK 3 13 2.1053 - 2.0499 0.99 2762 147 0.1920 0.2769 REMARK 3 14 2.0499 - 2.0000 0.99 2796 145 0.1854 0.2258 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.820 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.64 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2344 REMARK 3 ANGLE : 0.843 3187 REMARK 3 CHIRALITY : 0.057 345 REMARK 3 PLANARITY : 0.005 410 REMARK 3 DIHEDRAL : 19.867 1405 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6IUP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-DEC-18. REMARK 100 THE DEPOSITION ID IS D_1300009918. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40623 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 32.118 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 2.143 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.13 REMARK 200 R MERGE FOR SHELL (I) : 0.29700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.880 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.16 REMARK 200 STARTING MODEL: 4QQT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES PH5.5, 0.2M LI2SO4, 18% REMARK 280 PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.57500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 432 REMARK 465 GLY A 433 REMARK 465 SER A 434 REMARK 465 SER A 435 REMARK 465 HIS A 436 REMARK 465 HIS A 437 REMARK 465 HIS A 438 REMARK 465 HIS A 439 REMARK 465 HIS A 440 REMARK 465 HIS A 441 REMARK 465 SER A 442 REMARK 465 SER A 443 REMARK 465 GLY A 444 REMARK 465 LEU A 445 REMARK 465 LEU A 446 REMARK 465 ALA A 447 REMARK 465 GLY A 448 REMARK 465 LEU A 449 REMARK 465 VAL A 450 REMARK 465 SER A 451 REMARK 465 ASP A 507 REMARK 465 ASN A 508 REMARK 465 PRO A 568 REMARK 465 GLY A 569 REMARK 465 PRO A 570 REMARK 465 ASP A 571 REMARK 465 LEU A 572 REMARK 465 SER A 573 REMARK 465 PRO A 574 REMARK 465 ASP A 575 REMARK 465 GLY A 576 REMARK 465 SER A 751 REMARK 465 GLU A 752 REMARK 465 GLU A 753 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 452 CG CD1 CD2 REMARK 470 ASP A 453 CG OD1 OD2 REMARK 470 LYS A 471 CG CD CE NZ REMARK 470 GLN A 480 CG CD OE1 NE2 REMARK 470 LYS A 506 CG CD CE NZ REMARK 470 ARG A 529 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 543 CG CD OE1 OE2 REMARK 470 SER A 580 OG REMARK 470 GLU A 622 CG CD OE1 OE2 REMARK 470 LYS A 644 CG CD CE NZ REMARK 470 ASN A 648 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 611 -10.28 85.17 REMARK 500 ASP A 612 56.46 -145.35 REMARK 500 HIS A 639 54.97 -145.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AX0 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6ITJ RELATED DB: PDB REMARK 900 RELATED ID: 6IUO RELATED DB: PDB DBREF 6IUP A 445 753 UNP P22455 FGFR4_HUMAN 445 753 SEQADV 6IUP MET A 432 UNP P22455 INITIATING METHIONINE SEQADV 6IUP GLY A 433 UNP P22455 EXPRESSION TAG SEQADV 6IUP SER A 434 UNP P22455 EXPRESSION TAG SEQADV 6IUP SER A 435 UNP P22455 EXPRESSION TAG SEQADV 6IUP HIS A 436 UNP P22455 EXPRESSION TAG SEQADV 6IUP HIS A 437 UNP P22455 EXPRESSION TAG SEQADV 6IUP HIS A 438 UNP P22455 EXPRESSION TAG SEQADV 6IUP HIS A 439 UNP P22455 EXPRESSION TAG SEQADV 6IUP HIS A 440 UNP P22455 EXPRESSION TAG SEQADV 6IUP HIS A 441 UNP P22455 EXPRESSION TAG SEQADV 6IUP SER A 442 UNP P22455 EXPRESSION TAG SEQADV 6IUP SER A 443 UNP P22455 EXPRESSION TAG SEQADV 6IUP GLY A 444 UNP P22455 EXPRESSION TAG SEQADV 6IUP GLU A 664 UNP P22455 ARG 664 ENGINEERED MUTATION SEQRES 1 A 322 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 322 LEU LEU ALA GLY LEU VAL SER LEU ASP LEU PRO LEU ASP SEQRES 3 A 322 PRO LEU TRP GLU PHE PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 4 A 322 LYS PRO LEU GLY GLU GLY CYS PHE GLY GLN VAL VAL ARG SEQRES 5 A 322 ALA GLU ALA PHE GLY MET ASP PRO ALA ARG PRO ASP GLN SEQRES 6 A 322 ALA SER THR VAL ALA VAL LYS MET LEU LYS ASP ASN ALA SEQRES 7 A 322 SER ASP LYS ASP LEU ALA ASP LEU VAL SER GLU MET GLU SEQRES 8 A 322 VAL MET LYS LEU ILE GLY ARG HIS LYS ASN ILE ILE ASN SEQRES 9 A 322 LEU LEU GLY VAL CYS THR GLN GLU GLY PRO LEU TYR VAL SEQRES 10 A 322 ILE VAL GLU CYS ALA ALA LYS GLY ASN LEU ARG GLU PHE SEQRES 11 A 322 LEU ARG ALA ARG ARG PRO PRO GLY PRO ASP LEU SER PRO SEQRES 12 A 322 ASP GLY PRO ARG SER SER GLU GLY PRO LEU SER PHE PRO SEQRES 13 A 322 VAL LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 14 A 322 GLN TYR LEU GLU SER ARG LYS CYS ILE HIS ARG ASP LEU SEQRES 15 A 322 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 16 A 322 LYS ILE ALA ASP PHE GLY LEU ALA ARG GLY VAL HIS HIS SEQRES 17 A 322 ILE ASP TYR TYR LYS LYS THR SER ASN GLY ARG LEU PRO SEQRES 18 A 322 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP GLU VAL SEQRES 19 A 322 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY ILE LEU SEQRES 20 A 322 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 21 A 322 GLY ILE PRO VAL GLU GLU LEU PHE SER LEU LEU ARG GLU SEQRES 22 A 322 GLY HIS ARG MET ASP ARG PRO PRO HIS CYS PRO PRO GLU SEQRES 23 A 322 LEU TYR GLY LEU MET ARG GLU CYS TRP HIS ALA ALA PRO SEQRES 24 A 322 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ALA LEU SEQRES 25 A 322 ASP LYS VAL LEU LEU ALA VAL SER GLU GLU HET AX0 A 801 33 HET DMS A 802 4 HETNAM AX0 N-{4-[4-AMINO-3-(3,5-DIMETHYL-1-BENZOFURAN-2-YL)-7-OXO- HETNAM 2 AX0 6,7-DIHYDRO-2H-PYRAZOLO[3,4-D]PYRIDAZIN-2- HETNAM 3 AX0 YL]PHENYL}PROP-2-ENAMIDE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 AX0 C24 H20 N6 O3 FORMUL 3 DMS C2 H6 O S FORMUL 4 HOH *276(H2 O) HELIX 1 AA1 PRO A 463 ASP A 465 5 3 HELIX 2 AA2 SER A 510 GLY A 528 1 19 HELIX 3 AA3 ASN A 557 ALA A 564 1 8 HELIX 4 AA4 SER A 585 ARG A 606 1 22 HELIX 5 AA5 ALA A 614 ARG A 616 5 3 HELIX 6 AA6 LEU A 651 MET A 656 5 6 HELIX 7 AA7 ALA A 657 GLU A 664 1 8 HELIX 8 AA8 THR A 667 THR A 684 1 18 HELIX 9 AA9 PRO A 694 GLU A 704 1 11 HELIX 10 AB1 PRO A 715 TRP A 726 1 12 HELIX 11 AB2 ALA A 729 ARG A 733 5 5 HELIX 12 AB3 THR A 735 ALA A 749 1 15 SHEET 1 AA1 5 LEU A 467 PRO A 472 0 SHEET 2 AA1 5 VAL A 481 PHE A 487 -1 O ARG A 483 N GLY A 470 SHEET 3 AA1 5 ALA A 497 MET A 504 -1 O VAL A 502 N VAL A 482 SHEET 4 AA1 5 TYR A 547 GLU A 551 -1 O VAL A 550 N ALA A 501 SHEET 5 AA1 5 LEU A 536 CYS A 540 -1 N LEU A 537 O ILE A 549 SHEET 1 AA2 2 VAL A 618 VAL A 620 0 SHEET 2 AA2 2 MET A 626 ILE A 628 -1 O LYS A 627 N LEU A 619 SITE 1 AC1 14 CYS A 477 VAL A 481 ALA A 501 LYS A 503 SITE 2 AC1 14 GLU A 520 VAL A 550 GLU A 551 CYS A 552 SITE 3 AC1 14 ALA A 553 GLY A 556 LEU A 619 ASP A 630 SITE 4 AC1 14 DMS A 802 HOH A 908 SITE 1 AC2 4 VAL A 481 LYS A 503 ASP A 630 AX0 A 801 CRYST1 42.400 61.150 61.400 90.00 99.22 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023585 0.000000 0.003827 0.00000 SCALE2 0.000000 0.016353 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016500 0.00000